High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.

Aid Z, Robert E, Lopez CK, Bourgoin M, Boudia F, Le Mene M, Riviere J, Baille M, Benbarche S, Renou L, Fagnan A, Thirant C, Federici L, Touchard L, Lecluse Y, Jetten A, Geoerger B, Lapillonne H, Solary E, Gaudry M, Meshinchi S, Pflumio F, Auberger P, Lobry C, Petit A, Jacquel A, Mercher T

Open source

DOI: 10.1038/s41375-022-01800-0
Published: 2023 Mar
Container: Leukemia
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41375-022-01800-0,
  title = {High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.},
  author = {Aid Z and Robert E and Lopez CK and Bourgoin M and Boudia F and Le Mene M and Riviere J and Baille M and Benbarche S and Renou L and Fagnan A and Thirant C and Federici L and Touchard L and Lecluse Y and Jetten A and Geoerger B and Lapillonne H and Solary E and Gaudry M and Meshinchi S and Pflumio F and Auberger P and Lobry C and Petit A and Jacquel A and Mercher T},
  year = {2023},
  journal = {Leukemia},
  doi = {10.1038/s41375-022-01800-0},
  url = {https://doi.org/10.1038/s41375-022-01800-0}
}

RIS

TY  - JOUR
TI  - High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.
AU  - Aid Z
AU  - Robert E
AU  - Lopez CK
AU  - Bourgoin M
AU  - Boudia F
AU  - Le Mene M
AU  - Riviere J
AU  - Baille M
AU  - Benbarche S
AU  - Renou L
AU  - Fagnan A
AU  - Thirant C
AU  - Federici L
AU  - Touchard L
AU  - Lecluse Y
AU  - Jetten A
AU  - Geoerger B
AU  - Lapillonne H
AU  - Solary E
AU  - Gaudry M
AU  - Meshinchi S
AU  - Pflumio F
AU  - Auberger P
AU  - Lobry C
AU  - Petit A
AU  - Jacquel A
AU  - Mercher T
PY  - 2023
JO  - Leukemia
DO  - 10.1038/s41375-022-01800-0
UR  - https://doi.org/10.1038/s41375-022-01800-0
ER  -

APA

Z, A., E, R., CK, L., M, B., F, B., M, L. M., J, R., M, B., S, B., L, R., A, F., C, T., L, F., L, T., Y, L., A, J., B, G., H, L., E, S., M, G., S, M., F, P., P, A., C, L., A, P., A, J., & T, M. (2023). High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.. Leukemia. https://doi.org/10.1038/s41375-022-01800-0

Source records

pubmed · retrieved 2026-09-25T17:07:56.349Z